Sort
48,018 grants matching “immunotherapy”
Center for Immunotherapies to Zoonotic Diseases
$1,734,583Montana State University (Bozeman) · P20 · FY2004 · RR
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$1,733,876Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA
Pacific Ovarian Cancer Research Consoritum
$1,733,829Fred Hutchinson Cancer Research Center · P50 · FY2004 · CA
Molecular Pharmacology Lab
$1,733,779Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2020 · CA
Precision Medicine of Cancer
$1,733,722Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Innate immune regulation of inflammation and adaptive immunity
$1,733,579Anthony L. Defranco · University Of California, San Francisco · P01 · FY2011 · AI
Comparative Modeling of Lung Cancer Prevention, Early Detection and Treatment Interventions
$1,732,423Rafael Meza · University Of Michigan At Ann Arbor · U01 · FY2021 · CA
PROTECTIVE AND DAMAGING LYMPHOCYTE RESPONSES IN THE LUNG
$1,732,404Trudeau Institute, Inc. · P01 · FY2001 · HL
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
$1,731,885Nancy E Davidson · Fred Hutchinson Cancer Research Center · UM1 · FY2021 · CA
Mechanisms of Allergen Sensing and the Development of Allergic Sensitization
$1,731,705Beatriz Leãn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network
$1,731,705William E. Carson · Ohio State University · UM1 · FY2025 · CA
Mechanisms of Peripheral Induction of T-cell Tolerance
$1,729,938Kristin A. Hogquist · University Of Minnesota · P01 · FY2016 · AI
Clinical Vector for TCR Immunotherapy Targeted to Melanoma
$1,729,819Boro Dropulic · Lentigen Corporation · R44 · FY2012 · CA
ADULT AIDS CLINICAL TRIALS UNIT
$1,729,811University Of California San Francisco · U01 · FY2001 · AI
Elafin Therapy for Pulmonary Arterial Hypertension
$1,729,729Marlene Rabinovitch · Stanford University · P01 · FY2020 · HL
Elafin Therapy for Pulmonary Arterial Hypertension
$1,729,729Marlene Rabinovitch · Stanford University · P01 · FY2021 · HL
Elafin Therapy for Pulmonary Arterial Hypertension
$1,728,355Marlene Rabinovitch · Stanford University · P01 · FY2019 · HL
Overcoming BRAF-inhibitor Resistance in Melanoma
$1,726,864Antoni Ribas · University Of California Los Angeles · P01 · FY2013 · CA
Development of a Novel Resolvin-Based Therapy for Treatment of Pancreatic Cancer
$1,725,203John Parkinson · Thetis Pharmaceuticals, Llc · R44 · FY2025 · CA
Cytokine and immunotherapy in cancer and AIDS
$1,725,137Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Nucleic acid-based vaccine for HIV and other indications
$1,725,137Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
SPORE in Ovarian Cancer
$1,725,000Fox Chase Cancer Center · P50 · FY2004 · CA
Blood Stem Cell Transplantation as Immunotherapy
$1,724,891Samuel Strober · Stanford University · P01 · FY2016 · HL
ADULT AIDS CLINICAL TRIALS UNIT
$1,724,582New York University School Of Medicine · U01 · FY2005 · AI
ADULT AIDS CLINICAL TRIALS GROUP
$1,724,255University Of Alabama At Birmingham · U01 · FY2000 · AI